$2.31
0.02 (+0.87%)
Keryx Biopharmaceuticals (KERX)
CAPS Rating:
A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

RSS Headlines
Fool UK